Times, Health News, ET HealthWorld

AstraZeneca sold a 7.7% stake in Moderna Inc for more than $ 1 billion after a surge in shares in a US biotechnology company against the backdrop of breakthroughs in the corona virus vaccine, the Times reported.

The report added that it was unclear how long the UK-based AstraZeneca sold its holdings in Moderna.

AstraZeneca and Moderna did not immediately respond to the request for comment.

AstraZeneca maintains a partnership with Moderna for the treatment of other diseases and may sell the AstraZeneca / Oxford University Covid-19 vaccine on a commercial basis in the future if the virus becomes endemic. The report added that there is.

Moderna, which has been granted emergency use for Covid-19 in the United States, said last week it expects $ 18.4 billion in sales from this year’s coronavirus vaccine.

Follow us and connect with us , Facebook, LinkedIn

Back to top button